Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

In this real-world contemporary cohort of patients with AF receiving oral anticoagulants, DOAC use was associated with a lower risk of all-cause mortality and cardiovascular events across all stages of CKD. Trial registration NCT02219984.

Authors

Institutions

Publication Details

Journal
Clinical Research in Cardiology
Published
2025-11-03
DOI
https://doi.org/10.1007/s00392-025-02765-7
Citations
2
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
2.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Alessandra Serrao, Gualtiero Palareti, Raimondo De Cristofaro, Erica De Candia et al.
2 citations
Clinical Research in Cardiology
Atrial Fibrillation Management and Outcomes
2.78
article

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Alessandra Serrao, Gualtiero Palareti, Raimondo De Cristofaro, Erica De Candia, Carmine Spataro, Margherita Reduzzi, Elvira Grandone, Simona Pedrini, Donatella Colaizzo, Francesco Cibecchini, Marcello Di Nisio, Arianna Pani, Anna Falanga, Daniele Pastori, Teresa Lerede, Giovanni Nante, Benilde Cosmi, Doris Barcellona, Danilo Menichelli, Sophie Testa, Antonio Ciampa, Chiara Ambaglio, Vincenzo Oriana, Giovanni Barillari, Daniela Poli, L. Crippa, Marco Marzolo, Rossella Marcucci, S. Pezzella, Serena Rupoli, Carmelo Paparo, Gianluca Gazzaniga, Emilia Antonucci, Paolo Chiarugi, Elena Lotti, Antonio Insana, Salvatore Bradamante, Valeria Micheli, Vincenza Rossi, Giuliana Martini, L. Ruocco, Catello Mangione, Oriana Paoletti, Walter Ageno, Martina Berteotti, Giacomo Lucarelli, Domenico Lione, Paola Casasco, Paolo Pedico, Antonio Chistolini, Antonietta Piana, Domizio Serra, Eugenio Bucherini, Giuseppe Malcangi, Igor Diemberger, Vittorio Pengo, Monica Vastola, Giovanna Colombo, R Lombardi, Nicola Lucio Liberato, Giuseppe Boriani, Luca Bucherini, Servizio Analisi
article en
2 citations

Abstract

In this real-world contemporary cohort of patients with AF receiving oral anticoagulants, DOAC use was associated with a lower risk of all-cause mortality and cardiovascular events across all stages of CKD. Trial registration NCT02219984.

Clinical Research in Cardiology
University of Milan (IT), Istituto Neurologico Mediterraneo (IT), Azienda Ospedaliero-Universitaria Careggi (IT), ANT Foundation Italy Onlus (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 8%
Atrial Fibrillation Management and Outcomes
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.